Thorbald van Hall

Leiden University Medical Center — Netherlands

Immunology and Microbiology · Life Sciences

55h-index11.3kcitations337works4.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(137), Immune Cell Function and Interaction(91), Cancer Immunotherapy and Biomarkers(83), Monoclonal and Polyclonal Antibodies Research(71), Virus-based gene therapy research(67)

Publications337 total

Pyroglutamation of cell surface proteins CD47 and TRP1 by glutaminyl cyclase modulates therapeutic antibody binding
Communications Biology·2025· 1 citedOpen Access
887 Mechanistic role of signal peptide peptidase in Qa-1-mediated antigen presentation and tumor immunity
Regular and Young Investigator Award Abstracts·2025Open Access
TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study
Nature Communications·2025· 7 citedOpen Access
Site-directed multivalent conjugation of antibodies to ubiquitinated payloads
Nature Biomedical Engineering·2025· 5 citedOpen Access
Improving CD3 bispecific antibody therapy in solid tumors using combination strategies
Frontiers in Oncology·2025· 3 citedOpen Access
Cancer vaccines compensate for the insufficient induction of protective tumor-specific immunity of CD3 bispecific antibody therapy
Journal for ImmunoTherapy of Cancer·2025· 3 citedOpen Access
Myeloid effector cells in cancer
Cancer Cell·2024· 20 citedOpen Access
496 Pre-clinical development of a TCRm antibody targeting MHC-E complexes presenting signal peptides from classical MHC class I disrupts the NKG2A:MHC-E immune checkpoint and promotes anti-tumor immunity
Regular and Young Investigator Award Abstracts·2024Open Access
Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy
Cancer Cell·2024· 118 citedOpen Access
Figure S2 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S6 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S6 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Supplementary Tables S1-S3 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S10 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S11 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S1 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S8 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S7 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S14 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
Figure S9 from Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies
2024Open Access
page 1 of 17Next →

Frequent Co-authors

Sjoerd H. van der Burg(25), Ferry Ossendorp(12), Marjolein Sluijter(11), Cornelis J.M. Melief(9), Rienk Offringa(8), Peter A. van Veelen(7), Marcel Camps(6), Jan W. Drijfhout(6), Koen A. Marijt(5), Ekaterina S. Jordanova(5), Ramon Arens(4), Elien M. Doorduijn(4), Nadine van Montfoort(4), Selina Khan(4), Arnoud de Ru(4), Cláudia C. Oliveira(4), Floris Dammeijer(3), Menno van Nimwegen(3), Joachim G.J.V. Aerts(3), Mark J.A. Schoonderwoerd(3)